Columnist Ann Reynoso says she can't get used to the chronic cough of PF, but she's working to overcome the fear and ...

Two Phase 3 clinical trials testing Tyvaso (treprostinil) in people with idiopathic pulmonary fibrosis (IPF) both met their ...

As he navigates his rare disease journey, columnist Samuel Kirton feels it is his responsibility to be a "five-star patient." ...

Brainomix and Boehringer Ingelheim will advance testing of an AI-based analysis tool that may enable earlier diagnosis of PF.

Insilico Medicine will soon launch an early clinical trial in China to test an inhaled version of its therapy candidate rentosertib in healthy volunteers and people with idiopathic pulmonary fibrosis ...

Enrollment has finished ahead of schedule in a Phase 2 clinical trial testing Calluna Pharma‘s experimental antibody therapy CAL101 in people with idiopathic pulmonary fibrosis (IPF). The Phase 2 ...

A 24-hour news cycle, a lack of civil discourse, people who believe their needs are a priority, and the stress of a chronic, progressive disease with no cure: These things, and many more, contribute ...

Abnormalities in DNA methylation — a type of genetic modification that can alter the activity of a gene without changing its sequence — may affect a person’s risk of developing idiopathic pulmonary ...

Fast shallow breathing (tachypnea) is one of several breathing difficulties experienced by pulmonary fibrosis (PF) patients. Breathing problems are common in PF because the disease causes progressive ...

My name is Kylene, and if you haven’t read my column before, my husband, Donnie, was diagnosed with pulmonary fibrosis in late 2022. Right now, it’s 5 a.m., and I’m writing from our hotel room. Twice ...

Have you ever woken up in a strange mood and, before your feet hit the floor, found yourself wondering what caused it? I recently experienced that; I was feeling melancholy, and the Dean Lewis song ...